Compare Applovin Corporation (APP) vs Sana Biotechnology Inc (SANA) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Applovin Corporation vs Sana Biotechnology Inc — how do they compare? Applovin Corporation trades at $316.66 (market cap $106.65B), while Sana Biotechnology Inc trades at $3.78 (market cap $1.13B). The key difference: Applovin Corporation is far larger — about 94.4× Sana Biotechnology Inc's market cap, and Sana Biotechnology Inc is trading nearer its 52-week high, Applovin Corporation nearer its low. Which is the better fit depends on your goals.
| APP | SANA | |
|---|---|---|
Market Cap | $106.65B | $1.13B |
Sector | Technology | Health |
52-Week High | $733.60 | $5.92 |
52-Week Low | $318.68 | $2.68 |
Enterprise Value | $107.11B | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Applovin Corporation
AppLovin provides a software platform for mobile app developers to market, monetize, and analyze their apps. Its AI-powered tools help developers grow their business by connecting them with global advertising networks.
Read more on APP →About Sana Biotechnology Inc
Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →
